US Edition
Endometriosis market to grow to $2.5 billion across 7MM in 2034, forecasts GlobalData
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Endometriosis market to grow to $2.5 bn across 7MM in 2034 - Express Pharma
The endometriosis market across the seven major markets (7MM*) is forecast to increase at a compound annual growth rate (CAGR) of 10.3 per cent from $938.0 million in 2024 to $2.5 billion in 2034, forecasts GlobalData. GlobalData’s latest report, “Endometriosis: Seven Market Drug Forecast and Market Analysis,” reveals that the strong growth of the endometriosis market will be primarily fueled by the introduction of several key pipeline therapies…
Endometriosis market to grow to $2.5 billion across 7MM in 2034, forecasts GlobalData
The endometriosis market across the seven major markets (7MM*) is forecast to increase at a compound annual growth rate (CAGR) of 10.3% from $938.0 million in 2024 to $2.5 billion in 2034, forecasts GlobalData, a leading data and analytics company. GlobalData’s latest report, “Endometriosis: Seven Market Drug Forecast and Market Analysis,” reveals that the strong growth of the endometriosis market will be primarily fueled by the introduction of …
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
